Literature DB >> 23376672

Using a bradykinin blocker in ACE inhibitor-associated angioedema in the emergency department.

Andrew Volans1, Robert Ferguson.   

Abstract

We report two cases of ACE inhibitor-associated angioedema and critical airway compromise, where the use of a selective bradykinin 2 receptor blocker resulted in rapid symptom resolution and prevented intubation to protect the airway.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23376672      PMCID： PMC3603771          DOI： 10.1136/bcr-2012-008295

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  13 in total

1.  Local bradykinin generation in hereditary angioedema.

Authors:  J Nussberger; M Cugno; M Cicardi; A Agostoni
Journal:  J Allergy Clin Immunol       Date:  1999-12       Impact factor: 10.793

2.  ACE inhibitor use and severe angioedema.

Authors:  A Murray; J Crowther
Journal:  Postgrad Med J       Date:  1998-09       Impact factor: 2.401

3.  Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group.

Authors:  M Cicardi; K Bork; T Caballero; T Craig; H H Li; H Longhurst; A Reshef; B Zuraw
Journal:  Allergy       Date:  2011-11-30       Impact factor: 13.146

4.  Hereditary angioedema: a survey of UK emergency departments and recommendations for management.

Authors:  Thiagarajan Jaiganesh; Chris Hughan; Anthony Webster; Claire Bethune
Journal:  Eur J Emerg Med       Date:  2012-08       Impact factor: 2.799

Review 5.  Diagnosis and management of hereditary angioedema: an emergency medicine perspective.

Authors:  Joseph J Moellman; Jonathan A Bernstein
Journal:  J Emerg Med       Date:  2012-01-27       Impact factor: 1.484

6.  Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema.

Authors:  Marco Cicardi; Aleena Banerji; Francisco Bracho; Alejandro Malbrán; Bernd Rosenkranz; Marc Riedl; Konrad Bork; William Lumry; Werner Aberer; Henning Bier; Murat Bas; Jens Greve; Thomas K Hoffmann; Henriette Farkas; Avner Reshef; Bruce Ritchie; William Yang; Jürgen Grabbe; Shmuel Kivity; Wolfhart Kreuz; Robyn J Levy; Thomas Luger; Krystyna Obtulowicz; Peter Schmid-Grendelmeier; Christian Bull; Brigita Sitkauskiene; William B Smith; Elias Toubi; Sonja Werner; Suresh Anné; Janne Björkander; Laurence Bouillet; Enrico Cillari; David Hurewitz; Kraig W Jacobson; Constance H Katelaris; Marcus Maurer; Hans Merk; Jonathan A Bernstein; Conleth Feighery; Bernard Floccard; Gerald Gleich; Jacques Hébert; Martin Kaatz; Paul Keith; Charles H Kirkpatrick; David Langton; Ludovic Martin; Christiane Pichler; David Resnick; Duane Wombolt; Diego S Fernández Romero; Andrea Zanichelli; Francesco Arcoleo; Jochen Knolle; Irina Kravec; Liying Dong; Jens Zimmermann; Kimberly Rosen; Wing-Tze Fan
Journal:  N Engl J Med       Date:  2010-08-05       Impact factor: 91.245

Review 7.  The bradykinin-forming cascade and its role in hereditary angioedema.

Authors:  Allen P Kaplan; Kusumam Joseph
Journal:  Ann Allergy Asthma Immunol       Date:  2010-03       Impact factor: 6.347

8.  Factor XII mutations, estrogen-dependent inherited angioedema, and related conditions.

Authors:  Karen E Binkley
Journal:  Allergy Asthma Clin Immunol       Date:  2010-07-28       Impact factor: 3.406

9.  Management of hereditary angioedema: 2010 Canadian approach.

Authors:  Tom Bowen; John Brosz; Kristylea Brosz; Jacques Hebert; Bruce Ritchie
Journal:  Allergy Asthma Clin Immunol       Date:  2010-07-28       Impact factor: 3.406

10.  Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant).

Authors:  Konrad Bork; Jorge Frank; Boris Grundt; Peter Schlattmann; Juerg Nussberger; Wolfhart Kreuz
Journal:  J Allergy Clin Immunol       Date:  2007-04-05       Impact factor: 10.793
View more
  3 in total

1.  Treatment of ACEI-related angioedema with icatibant: a case series.

Authors:  Maria Bova; Mar Guilarte; Anna Sala-Cunill; Paolo Borrelli; Grazia Maria Luisa Rizzelli; Andrea Zanichelli
Journal:  Intern Emerg Med       Date:  2015-02-10       Impact factor: 3.397

2.  Orolingual angioedema to alteplase. Identify, counsel and monitor at risk patients.

Authors:  Christopher Timmis; Elliot Epstein; Mohmad Salim
Journal:  BMJ Case Rep       Date:  2016-09-02

Review 3.  Efficacy of Treatment of Non-hereditary Angioedema.

Authors:  Mignon van den Elzen; M F C L Go; A C Knulst; M A Blankestijn; H van Os-Medendorp; H G Otten
Journal:  Clin Rev Allergy Immunol       Date:  2018-06       Impact factor: 8.667
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.